RankAlpha logo
Back to Rankings

ASND

Ascendis A/SF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Successful clinical readouts, clear regulatory paths, or a strategic partnership could drive material re-rating; commercial execution on approved programs would further de-risk the story.
Posture
Defensive
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-09-10.
What can break
Clinical trial failure or negative readout
Momentum
42
Value
58
Sentiment
0
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $28.16 · Bull $46.08 · Bear $12.80Analysis 2025-10-02; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-02 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $314.21
Why
Momentum42 · Δ7d +19.1
Value58 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Bullish). Prioritize risk control and patience.

Confirming evidence

  • • 6 setup hits (3d) with net bullish as of 2026-09-10.
  • • Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

  • • Clinical trial failure or negative readout
  • • Insufficient cash runway leading to dilution
  • • Clinical setbacks, regulatory delays, or faster-than-expected cash burn without fresh financing could materially compress the valuation and force dilution.

Catalyst clock

No dated catalyst is available.

Quarterly earnings / cash-runway update

Lead driver: Value · See fundamentals
Momentum
42
9% active weight
Current posture
7d trendImproving
Δ7d
+19.1
Δ21d
+2.8
Value
58
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+9.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade F. Momentum 41.6 / Value 57.6 / Sentiment 0.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-10-02. Scenario method

B+
Bull case
25%
Probability
Target price
$46.08
Analysis reference price unavailable
Analysis 2025-10-02 · RankAlpha Sentiment AI
Most likely
B
Base case
50%
Probability
Target price
$28.16
Analysis reference price unavailable
Analysis 2025-10-02 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$12.80
Analysis reference price unavailable
Analysis 2025-10-02 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$15.43B
Beta
0.43
Shares Out
65.67M
P/E (TTM) · Derived
-55.3
P/S (TTM)
17.35
P/FCF (TTM) · Derived
40.42
Rev YoY
+120.2%
EPS YoY
-613.4%
Gross Margin
+89.8%
Op Margin
+10.3%
Net Debt
$300.36M
Current Ratio
2.99
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data